Polypeptides Having Xylanase Activity And Polynucleotides Encoding Same

Patent No. EP3091073 (titled "Polypeptides Having Xylanase Activity And Polynucleotides Encoding Same") was filed by Novozymes on Aug 1, 2012. The application was issued on Mar 8, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BASFDec 20, 2018BASF ASSOCIATION

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3091073

NOVOZYMES
Application Number
EP16170376A
Filing Date
Aug 1, 2012
Status
Patent Maintained As Amended
Feb 3, 2023
Publication Date
Mar 8, 2023